Project Grant HDTRA12210002
Award Date
10/12/21
Completion Date
10/11/23
Dollars Obligated
$264K
Federal Agency
Defense Threat Reduction Agency
Federal Grant Program
12.351
Assistance Type
Project Grant
Place of Performance
Manassas, VA 20110, USA
Similar Awards
The Defense Threat Reduction Agency (DTRA) awarded a $100,000 Project Grant under the Scientific Research - Combating Weapons of Mass Destruction (CFDA 12.351) program to the University of New Mexico Health Sciences Center (UNM HSC) on December 18, 2024. The grant will support the development of an in vitro model for studying alphavirus infection, which is a key focus area for research on defending against chemical, biological, radiological, nuclear, and high-yield explosive threats. This...
This federal Project Grant award of $100,000.00 from the Defense Threat Reduction Agency (DTRA) under the Scientific Research - Combating Weapons of Mass Destruction (CFDA 12.351) program is supporting research at Virginia Polytechnic Institute & State University (Virginia Tech) to identify conserved host responses during infection of emerging viruses. The award, with a performance period from February 2025 to February 2030, will utilize complementary proteomic approaches to advance...
The Defense Threat Reduction Agency (DTRA) awarded a 5-year, $481,680 Project Grant under the Scientific Research - Combating Weapons of Mass Destruction (CFDA 12.351) federal grant program to the Puerto Rico Science, Technology, and Research Trust (PRSTRT), a minority-owned, Hispanic American non-profit organization. The objective of the grant is to develop methods to quickly identify natural products in extracts and human protein targets through the use of high-resolution mass spectrometry,...
The Defense Health Agency awarded a $215,429 Project Grant to The Global Alliance For TB Drug Development Inc. (TB Alliance) to investigate a host-directed proteolysis-targeting chimera (PROTAC) approach for targeting intracellular Mycobacterium tuberculosis. This two-year grant, running from July 2024 to July 2026, supports TB Alliance's research and development efforts to accelerate the development of new tuberculosis (TB) drugs and treatment regimens. The funding falls under the Military...
The Defense Health Agency awarded a $456,633 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. The grant funds the development and optimization of a platform for next-generation monoclonal antibodies against Powassan virus and other neuroinvasive tick-borne viruses. Key collaborators include researchers from the United States Army Medical Research Institute of Infectious...
The Department of the Army Medical Command awarded a $537,250 Project Grant to the University of Miami under the Military Medical Research and Development federal grant program (CFDA 12.420) to support research on oncolytic viruses for the treatment of adenoid cystic carcinoma. The three-year award beginning September 15, 2022 will fund the development of medical solutions using oncolytic viruses, a type of virus that selectively infects and kills cancer cells. As part of the Military Medical...
The U.S. Defense Health Agency awarded a $7,349,780 Project Grant to the University of Massachusetts Medical School (UMass Medical) to conduct research on "RNA Therapeutics for Infectious Diseases: Viral Hemorrhagic Fever" over a 4-year period from September 1, 2023 to August 31, 2027. This grant is funded through the Department of Defense's Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to develop innovative medical solutions for...
The University of Texas Medical Branch at Galveston (UTMB) received a $2,368,986 project grant award from the Defense Threat Reduction Agency (DTRA) on February 16, 2023 to complete work by February 15, 2026. The grant falls under the Scientific Research - Combating Weapons of Mass Destruction (CFDA 12.351) program to support fundamental knowledge and understanding of sciences related to combating WMDs. UTMB will conduct research on the ecological dynamics and improved surveillance of plague...
This $986,387 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to identify cellular proteins associated with adeno-associated virus (AAV) genomes. The goal is to improve understanding of the cellular factors that interact with AAV genomes to facilitate gene expression, DNA replication, genome encapsidation, and vector transduction. The researchers will employ a novel proteomics technology to...
This Project Grant from the Defense Threat Reduction Agency provides $668,000 in funding under the Scientific Research - Combating Weapons of Mass Destruction federal grant program (CFDA 12.351) to support fundamental research to counter weapons of mass destruction. Specifically, the University of California, Berkeley will utilize molecular dynamics simulations to understand how random heteropolymers arrange within and around metal organic frameworks and provide functions such as stabilizing...